7 Masimo SET ® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates, 3 improve CCHD screening in newborns, 5 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.
Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies. Our mission is to improve patient outcomes and reduce the cost of care. Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Thanks for encouraging me to try harder, and for encouraging others to try harder, to do the right | #Masimo Thank you again for this incredible award. That gift, which these two incredible friends have given me, has allowed me to feel fulfilled, and even though I know I’m just a speck in time and in space, at least we’ve been together, my dear friends, a useful speck, that may have given birth and happiness to more specks to enjoy the joy and pain of life, which is precious. Augusto Sola, who helped me with a great innovation, not only to innovate our measure-through-motion pulse oximetry, but to innovate a way to use it to help so many babies. Kiani continued, “I want to tell you how blessed I feel to have friends like Mohammad Diab and Dr. Susana Rodríguez and the board of SIBEN for honoring me with this meaningful award.” You know better than I that what’s common practice is unfortunately not always best practice – and your work – to educate, educate, educate – is critical in bridging that gap, so more babies get the best care possible. I also want to thank SIBEN for the incredible work you’re doing to bridge the gap between knowledge and what’s practiced. You have never stopped amazing me with how much you care for our babies, your patients. There’s so much apathy, and I think that’s the biggest hurdle to improving patient care – but not with neonatologists and neonatal nurses. Kiani said, “Thank you to all the neonatologists and the care providers around neonates. He received an Honorary Doctorate of Science from Chapman University, and is an Honorary member of the Mexican Academy of Surgery. Kiani has been named SafeCare’s Person of the Year and one of “50 Experts in Patient Safety” by Becker’s Hospital Review. To date, more than 4,700 hospitals in 50 countries have committed to this goal-and an estimated 93,000 lives are being saved annually. Kiani has long championed the importance of patient safety, and in 2013 created The Patient Safety Movement Foundation, dedicated to achieving zero preventable deaths by 2030. Kiani’s creativity and vision have led to many additional medical advancements in the years since, with Masimo, which recently celebrated its 31 st anniversary, remaining at the forefront of global medical innovation. 3 Today, SET ® pulse oximetry is used to monitor more than 200 millions patients each year, 4 and has been shown, among other benefits, to help improve critical congenital heart disease (CCHD) screening in newborns. 2 A later study showed that the protocol’s success depended on SET ® technology, as the same protocol with a competing pulse oximeter did not reduce ROP. Augusto Sola (Managing Director of SIBEN) and colleagues showed that using a new protocol with Masimo SET ®, clinicians reduced ROP to nearly zero over five years. In particular, use of SET ® has played a key role in reducing the rate of neonatal blindness (retinopathy of prematurity). Kiani’s commitment to neonatal care started with the invention, in 1995, of Masimo Signal Extraction Technology ®, or SET ®, pulse oximetry, whose breakthrough ability to measure through motion and low perfusion led to remarkable improvements in neonatal care.
1 SIBEN is comprised of more than 2,000 healthcare professionals associated with neonatal care.ĭr. SIBEN, founded in 2004, is dedicated to improving newborn care throughout Latin America-where 15 babies die every hour, with 60% of those who die before their first birthday dying during the first 28 days after birth. Kiani for his lifelong dedication to improving newborn care. In her award presentation, SIBEN Scientific Group member Dr.
IRVINE, Calif.-( BUSINESS WIRE)- Masimo (NASDAQ: MASI) announced today that its Founder, Chairman, and CEO, Joe Kiani, has been honored by the Ibero-American Society of Neonatology (SIBEN) at its 17 th Annual Congress (this year held virtually) with the Award for Improvement of Neonatal Health in Latin America.